THE SMART TRICK OF HEMGENIX THAT NOBODY IS DISCUSSING

Range of suitable people: CDEC discussed the uncertainty in the number of individuals with moderately serious to extreme hemophilia B in Canada qualified for etranacogene dezaparvovec. Clinical specialists consulted by CADTH indicated that some individuals who are classified as having mild or average sickness can have a critical bleeding phenotype,